KIT Blocking Peptide (Center)
Référence MBS9229442-0,5mg
Conditionnement : 0.5mg
Marque : MyBiosource
KIT Blocking Peptide (Center) Blocking Peptide
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9229442Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and… More details
Product Overview
Online Datasheet in PDFProduct Name
KIT, Blocking Peptide
Full Product Name
KIT Blocking Peptide (Center)
Product Gene Name
KIT blocking peptide
Product Synonym Gene Name
SCFR
Product Synonym Names
Mast/stem cell growth factor receptor Kit; SCFR; Piebald trait protein; PBT; Proto-oncogene c-Kit; Tyrosine-protein kinase Kit; p145 c-kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD117; KIT; SCFR
Form/Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Specificity
The synthetic peptide sequence is selected from aa 336-347 of HUMAN KIT
Preparation and Storage
Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.
Antibody/Peptide Pairs
KIT peptide (MBS9229442) is used for blocking the activity of KIT antibody (MBS9211754)
Molecular Weight
46,658 Da
OMIM
164920
Cellular Location
Isoform 1: Cell membrane; Single-pass type I membrane protein Isoform 3: Cytoplasm. Note: Detected in the cytoplasm of spermatozoa, especially in the equatorial and subacrosomal region of the sperm head
Tissue Location
Isoform 1 and isoform 2 are detected in spermatogonia and Leydig cells. Isoform 3 is detected in round spermatids, elongating spermatids and spermatozoa (at protein level). Widely expressed. Detected in the hematopoietic system, the gastrointestinal system, in melanocytes and in germ cells
Other Notes
Small volumes of KIT blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for KIT purchase
MBS9229442 is a blocking peptide targeting KIT. Also known as KIT Blocking Peptide (Center).
Additional Details
NCBI/Uniprot data below describe general gene information for KIT. It may not necessarily be applicable to this product.
NCBI Official Full Name
Mast/stem cell growth factor receptor Kit
NCBI Official Synonym Full Names
KIT proto-oncogene receptor tyrosine kinase
NCBI Official Symbol
KIT
NCBI Official Synonym Symbols
PBT; SCFR; C-Kit; CD117
UniProt Protein Name
Mast/stem cell growth factor receptor Kit
UniProt Synonym Protein Names
Piebald trait protein; PBT; Proto-oncogene c-Kit; Tyrosine-protein kinase Kit; p145 c-kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CD_antigen: CD117
Protein Family
Mast/stem cell growth factor receptor
UniProt Gene Name
KIT
UniProt Synonym Gene Names
SCFR; SCFR; PBT
UniProt Entry Name
KIT_HUMAN
NCBI Protein Information
mast/stem cell growth factor receptor Kit
NCBI Summary for KIT
This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for KIT
Kit: a receptor tyrosine kinase and a member of the subfamily that includes PDGF, CSF-1 and FLT-3/flk-2 receptors. Receptor for stem cell factor. Plays a critical role in hematopoietic stem cell, mast cell, melanocyte and germ cell development. Ligand binding induces autophosphorylation, dimerization and activation, leading to the recruitment and phosphorylation of downstream SH2-containing signaling components including PLC-gamma, PI3 kinase p85, SHP2 and CrkL, linking c-Kit to various cell signaling pathways. Molecular lesions that impair the kinase activity of c-Kit are associated with a variety of developmental disorders, while mutations that constitutively activate c-Kit can lead to hyperplasia and tumorigenesis. Activating mutations cause >90% of gastrointestinal stromal tumors (GIST); successfully treated with inhibitors Gleevec (imatinib, Glivec) and Sutent (Sutinib, SU11248). Activating mutations also induce mastocytosis. Autocrine/paracrine stimulation may drive some lung and other tumors. Loss of expression associated with melanoma progression. Familial loss of function mutations cause piebaldism, with defects in hair and skin pigmentation due to lack of melanocytes.
Protein type: Protein kinase, TK; Oncoprotein; Membrane protein, integral; EC 2.7.10.1; Kinase, protein; Protein kinase, tyrosine (receptor); TK group; PDGFR family
Chromosomal Location of Human Ortholog: 4q12
Cellular Component: extracellular space; plasma membrane
Molecular Function: cytokine binding; phosphatidylinositol-4,5-bisphosphate 3-kinase activity; protein binding; protein homodimerization activity; protein-tyrosine kinase activity; Ras guanyl-nucleotide exchange factor activity; transmembrane receptor protein tyrosine kinase activity
Biological Process: actin cytoskeleton reorganization; activation of MAPK activity; cytokine and chemokine mediated signaling pathway; dendritic cell cytokine production; detection of mechanical stimulus involved in sensory perception of sound; embryonic hemopoiesis; erythrocyte differentiation; gut development; hemopoiesis; immature B cell differentiation; inflammatory response; lamellipodium biogenesis; male gonad development; MAPKKK cascade; mast cell chemotaxis; mast cell cytokine production; mast cell degranulation; melanocyte differentiation; ovarian follicle development; peptidyl-tyrosine phosphorylation; phosphoinositide-mediated signaling; pigmentation; positive regulation of JAK-STAT cascade; positive regulation of MAPKKK cascade; positive regulation of phosphoinositide 3-kinase activity; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of transcription factor activity; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of tyrosine phosphorylation of Stat3 protein; positive regulation of tyrosine phosphorylation of Stat5 protein; protein amino acid autophosphorylation; regulation of cell proliferation; regulation of cell shape; regulation of phosphoinositide 3-kinase cascade; signal transduction; spermatogenesis; stem cell differentiation; stem cell maintenance; T cell differentiation
Disease: Gastrointestinal Stromal Tumor; Mast Cell Disease; Piebald Trait; Testicular Germ Cell Tumor
Show more Protein type: Protein kinase, TK; Oncoprotein; Membrane protein, integral; EC 2.7.10.1; Kinase, protein; Protein kinase, tyrosine (receptor); TK group; PDGFR family
Chromosomal Location of Human Ortholog: 4q12
Cellular Component: extracellular space; plasma membrane
Molecular Function: cytokine binding; phosphatidylinositol-4,5-bisphosphate 3-kinase activity; protein binding; protein homodimerization activity; protein-tyrosine kinase activity; Ras guanyl-nucleotide exchange factor activity; transmembrane receptor protein tyrosine kinase activity
Biological Process: actin cytoskeleton reorganization; activation of MAPK activity; cytokine and chemokine mediated signaling pathway; dendritic cell cytokine production; detection of mechanical stimulus involved in sensory perception of sound; embryonic hemopoiesis; erythrocyte differentiation; gut development; hemopoiesis; immature B cell differentiation; inflammatory response; lamellipodium biogenesis; male gonad development; MAPKKK cascade; mast cell chemotaxis; mast cell cytokine production; mast cell degranulation; melanocyte differentiation; ovarian follicle development; peptidyl-tyrosine phosphorylation; phosphoinositide-mediated signaling; pigmentation; positive regulation of JAK-STAT cascade; positive regulation of MAPKKK cascade; positive regulation of phosphoinositide 3-kinase activity; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of transcription factor activity; positive regulation of tyrosine phosphorylation of Stat1 protein; positive regulation of tyrosine phosphorylation of Stat3 protein; positive regulation of tyrosine phosphorylation of Stat5 protein; protein amino acid autophosphorylation; regulation of cell proliferation; regulation of cell shape; regulation of phosphoinositide 3-kinase cascade; signal transduction; spermatogenesis; stem cell differentiation; stem cell maintenance; T cell differentiation
Disease: Gastrointestinal Stromal Tumor; Mast Cell Disease; Piebald Trait; Testicular Germ Cell Tumor
Research Articles on KIT
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with KIT blocking peptide
| Reference Product | PubMed Publications |
|---|---|
| KITLG blocking peptide | >60 publications with KIT and KITLG |
| STAT1 blocking peptide | >59 publications with KIT and STAT1 |
| EPOR blocking peptide | >53 publications with KIT and EPOR |
| GRB2 blocking peptide | >41 publications with KIT and GRB2 |
| PTPN11 blocking peptide | >38 publications with KIT and PTPN11 |
| STAT5B blocking peptide | >13 publications with KIT and STAT5B |
| PIK3R1 blocking peptide | >7 publications with KIT and PIK3R1 |
| DOK1 blocking peptide | >3 publications with KIT and DOK1 |
| SOCS6 blocking peptide | >2 publications with KIT and SOCS6 |
| PIK3CG blocking peptide | >1 publications with KIT and PIK3CG |
Pathways associated with KIT blocking peptide
| Products by Pathway | Pathway Diagram |
|---|---|
| ARMS-mediated Activation Pathway antibodies | ARMS-mediated Activation Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| C-MYB Transcription Factor Network Pathway antibodies | C-MYB Transcription Factor Network Pathway Diagram |
| Cardiac Progenitor Differentiation Pathway antibodies | Cardiac Progenitor Differentiation Pathway Diagram |
| Central Carbon Metabolism In Cancer Pathway antibodies | Central Carbon Metabolism In Cancer Pathway Diagram |
| Central Carbon Metabolism In Cancer Pathway antibodies | Central Carbon Metabolism In Cancer Pathway Diagram |
| Constitutive Signaling By Aberrant PI3K In Cancer Pathway antibodies | Constitutive Signaling By Aberrant PI3K In Cancer Pathway Diagram |
Diseases associated with KIT blocking peptide
| Disease Name | Pubmed Publications |
|---|---|
| Gastrointestinal Stromal Tumors Antibodies | >2480 publications with KIT and Gastrointestinal Stromal Tumors |
| Inflammation Antibodies | >1571 publications with KIT and Inflammation |
| Liver Diseases Antibodies | >1447 publications with KIT and Liver Diseases |
| Lung Diseases Antibodies | >1385 publications with KIT and Lung Diseases |
| Necrosis Antibodies | >1273 publications with KIT and Necrosis |
| Heart Diseases Antibodies | >972 publications with KIT and Heart Diseases |
| Leukemia, Myeloid, Acute Antibodies | >962 publications with KIT and Leukemia, Myeloid, Acute |
| Breast Neoplasms Antibodies | >777 publications with KIT and Breast Neoplasms |
| Lung Neoplasms Antibodies | >759 publications with KIT and Lung Neoplasms |
| Neoplasm Metastasis Antibodies | >730 publications with KIT and Neoplasm Metastasis |
Organs/Tissues associated with KIT blocking peptide
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Muscle Antibodies | >2479 publications with KIT and Muscle |
| Liver Antibodies | >2334 publications with KIT and Liver |
| Skin Antibodies | >1732 publications with KIT and Skin |
| Lung Antibodies | >1718 publications with KIT and Lung |
| Heart Antibodies | >1518 publications with KIT and Heart |
| Brain Antibodies | >1227 publications with KIT and Brain |
| Intestine Antibodies | >1224 publications with KIT and Intestine |
| Kidney Antibodies | >1168 publications with KIT and Kidney |
| Embryonic Tissue Antibodies | >678 publications with KIT and Embryonic Tissue |
| Spleen Antibodies | >661 publications with KIT and Spleen |


